[Bacteriological development in the triple combination antituberculosis treatment].
D000636:Aminosalicylic Acids / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D013307:Streptomycin / Q000627:therapeutic use*; D013828:Thioacetazone / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy* / Q000517:prevention & control
D000636:Aminosalicylic Acids; D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin
Evolución bacteriologíca en el tratamiento antituberculoso de triple asociación.